Viewing Study NCT01224769


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-01-15 @ 8:43 PM
Study NCT ID: NCT01224769
Status: COMPLETED
Last Update Posted: 2010-10-21
First Post: 2010-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders
Sponsor: Gruppo Italiano Studio Linfomi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Chronic Lymphoproliferative Disorders View
Keywords: